About: Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.17 (-14.70%)
LABT NASDAQ Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock share price
LABT price activity
Last Price
$0.170
Change (24hr)
-0.03 USD (14.70%)
Volume
388.52K
Volume (4w avg)
-
Open
$0.19
Day Range
$0.17 - $0.19
Previous Close
$0.20
Last Trade
02 Nov, 2:37 pm GMT+0
Delayed
02 Nov, 2:37 pm GMT+0
LABT price performance
Delayed
02 Nov, 2:37 pm GMT+0
LABT Market Signals